Mingwei Wang
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Biological Psychiatry top 10%
Papers in
- Epidemiology 25
- Liver Disease Diagnosis and Treatment 6
-
- RNA modifications and cancer 5
- Co-authors
- Mengyun Zhou (29 shared papers)Zhanhui Feng (26 shared papers)Yongran Cheng (32 shared papers)Chunyi Wang (24 shared papers)Xingwei Zhang (17 shared papers)Jiake Tang (19 shared papers)Chen Chen (9 shared papers)Qi Wu (5 shared papers)
- Journals
- Journal of Infection (6 papers)Risk Management and Healthcare Policy (5 papers)Frontiers in Public Health (3 papers)Environmental Science and Pollution Research (3 papers)BMC Public Health (3 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Mingwei Wang
126 papers receiving 2.3k citations
Mingwei Wang's Hit Papers
Peers
Comparison fields: 5 of 180
- Infectious Diseases 427
- Biological Psychiatry 44
- Endocrinology, Diabetes and Metabolism 265
- Modeling and Simulation 53
- Neurology 173
Countries citing papers authored by Mingwei Wang
This map shows the geographic impact of Mingwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingwei Wang more than expected).
Fields of papers citing papers by Mingwei Wang
This network shows the impact of papers produced by Mingwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingwei Wang. The network helps show where Mingwei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes Hit paper breakdown → | 2016 | 288 |
| 2 | Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis Hit paper breakdown → | 2022 | 272 |
| 3 | Anxiety, depression, and stress prevalence among college students during the COVID-19 pandemic: A systematic review and meta-analysis Hit paper breakdown → | 2021 | 175 |
| 4 | 2020 | 114 | |
| 5 | 2020 | 72 | |
| 6 | 2010 | 69 | |
| 7 | 1991 | 65 | |
| 8 | 2011 | 60 | |
| 9 | 2020 | 56 | |
| 10 | 2021 | 54 | |
| 11 | 2003 | 48 | |
| 12 | 2022 | 46 | |
| 13 | 2010 | 42 | |
| 14 | 2018 | 40 | |
| 15 | 2007 | 39 | |
| 16 | 2009 | 38 | |
| 17 | 2006 | 35 | |
| 18 | 2022 | 32 | |
| 19 | 2022 | 31 | |
| 20 | 2010 | 28 |
About Mingwei Wang
Mingwei Wang is a scholar working on Epidemiology, Molecular Biology, Oncology, Surgery and Cardiology and Cardiovascular Medicine, having authored 144 papers that have together received 2.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Pandemic Impacts (7 papers), Peptidase Inhibition and Analysis (7 papers), Air Quality and Health Impacts (6 papers), Liver Disease Diagnosis and Treatment (6 papers), COVID-19 and healthcare impacts (6 papers), RNA modifications and cancer (5 papers) and Genetic factors in colorectal cancer (5 papers). The work is most often cited by research in Infectious Diseases (427 citations), Biological Psychiatry (44 citations), Endocrinology, Diabetes and Metabolism (265 citations), Modeling and Simulation (53 citations) and Neurology (173 citations). Mingwei Wang has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Mengyun Zhou, Zhanhui Feng, Yongran Cheng, Chunyi Wang, Xingwei Zhang, Jiake Tang, Chen Chen, Qi Wu, Wen Wen and Caihong Zhou. Their work appears in journals such as Journal of Infection, Risk Management and Healthcare Policy, Frontiers in Public Health, Environmental Science and Pollution Research and BMC Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.